Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

The dysfunction of the renin-angiotensin system (RAS) has been observed in coronavirus infection disease (COVID-19) patients, but whether RAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs), are associated with clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Juan, Xiao, Guohui, Zhang, Juanjuan, He, Xing, Ou, Min, Bi, Jing, Yang, Rongqing, Di, Wencheng, Wang, Zhaoqin, Li, Zigang, Gao, Hong, Liu, Lei, Zhang, Guoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170368/
https://www.ncbi.nlm.nih.gov/pubmed/32228222
http://dx.doi.org/10.1080/22221751.2020.1746200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170368/
https://www.ncbi.nlm.nih.gov/pubmed/32228222
http://dx.doi.org/10.1080/22221751.2020.1746200

Ejemplares similares